Impact of Patent Foramen Ovale (PFO) and Atrial Septal Defect (ASD) upon Travel to Extreme Altitude
Support: Henry Ford Health Global Health Initiative, USA
Partner: Shree Gangalal National Heart Center, National Association of Tours and Travel
Agents, Sherpa Tourism Entrepreneur Association Nepal
Status : Phase Out
Objectives: This project aims to assess the prevalence and physiological impact of Patent
Foramen Ovale (PFO) and Atrial Septal Defect (ASD) among adult Sherpas who are regularly
exposed to extreme altitudes above 4,000 meters. To achieve this, saline contrast (bubble) studies
will be conducted to identify 10 Sherpas with PFO or ASD, who will then undergo
cardiopulmonary fitness testing, peripheral oxygen saturation (SpO2) measurement, and body
temperature assessment. These tests will be conducted both at high altitude and at sea level and
compared against a control group of 10 Sherpas without PFO or ASD. In addition to data
collection, the project includes a strong capacity-building component by training local
cardiologists and cardiac nursing staff in conducting transthoracic echocardiography (TTE) with
bubble studies, enabling local health teams to conduct right heart screening independently and
strengthening their ability to assess cardiopulmonary risks associated with high-altitude
exposure.
Outcome: The expected outcomes of this project include generating evidence on the association
between interatrial shunts (PFO/ASD) and increased risk of hypoxemia, contributing to better
understanding the risk of high-altitude pulmonary and cerebral edema (HAPE and HACE)
among Sherpas. The findings will help guide the development of targeted cardiac screening
protocols for high-altitude workers, improving early identification of at-risk individuals.
Furthermore, by training local healthcare providers in advanced cardiac screening techniques, the
project will enhance local capacity for high-altitude cardiopulmonary risk assessment, ensuring
sustained benefits beyond the study period.